glp 1 gip vs glp 1 Science Behind and Glucagon Receptor Agonists for Obesity Research | News & Announcements Indications for GLP-1/GIP RA Summary
Description
GLP-1 drugs have become a game-changer in treating obesity and type 2 diabetes, forecast to reach a $100 billion market value by 2030
The year delivered progress across clinical evidence, policy, and changing market dimensions, reinforcing obesity as a chronic disease requiring structured, long-term management
Take a deep dive into Eli Lilly's latest clinical GLP-1 results that sent shares soaring
Your body depends on glucose for energy
